Phase I Trial of Poly-l-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid Malignancies
HOMSI, Jade, SIMON, George R, ANGIULI, Patrizia, EISENFELD, Amy, SULLIVAN, Daniel M, DAUD, Adil I, GARRETT, Chris R, SPRINGETT, Gregory, DE CONTI, Ronald, CHIAPPORI, Alberto A, MUNSTER, Pamela N, BURTON, Michelle K, STROMATT, Scott, ALLIEVI, Claudia
Published in Clinical cancer research (01.10.2007)
Published in Clinical cancer research (01.10.2007)
Get full text
Journal Article
Phase I Study of a Liposomal Carrier (CPX-351) Containing an Optimized, Synergistic, Fixed Molar Ratio of Cytarabine (Ara-C) and Daunorubicin (DNR) in Advanced Leukemias and Myelodysplastic Syndromes (MDS)
Feldman, Eric J., Lancet, Jeffrey E., Kolitz, Jonathan E., Asatiani, Ekatherine, Curcio, Tania J., Burton, Michelle K., Fricano, Marjorie, Begley, Amanda R., Swenson, Christine, Mayer, Lawrence, Janoff, Andrew S., Louie, Arthur C.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article